Bone turnover and periprosthetic bone loss after cementless total hip arthroplasty can be restored by zoledronic acid: a prospective, randomized, open-label, controlled trial

Peer Review reports

Original Submission
15 Feb 2017	Submitted	Original manuscript
5 Mar 2017	Reviewed	Reviewer Report - Gregor Freystätter
29 Mar 2017	Reviewed	Reviewer Report - Christian Ossendorf
3 May 2017	Author responded	Author comments - Tsan-Wen Huang
Resubmission - Version 2
3 May 2017	Submitted	Manuscript version 2
Publishing
12 May 2017	Editorially accepted
22 May 2017	Article published	10.1186/s12891-017-1577-2

Back to article page